Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Bioscience (Elite Edition)|May 31, 2011
EGFR genomic alterations in cancer: prognostic and predictive valuesGiuseppe Bronte, Marianna Terrasi, Sergio Rizzo, et al.
Cancer Treatment Reviews|December 7, 2010
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinomaGiuseppe Bronte, Sergio Rizzo, Laura La Paglia, et al.
Scientific Reports|November 20, 2018
Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysisFrancesco Passiglia, Sergio Rizzo, Massimo Di Maio, et al.
Oncotarget|April 16, 2016
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?Daniele Fanale, Valeria Amodeo, Viviana Bazan, et al.
Minerva Cardioangiologica|June 5, 2020
Uncoupling Protein 2 as genetic risk factor for systemic lupus erythematosus: association with malondialdehyde levels and intima media thicknessCaterina M Gambino, Giulia Accardi, Anna Aiello, et al.
Oncotarget|January 6, 2017
"Back to a false normality": new intriguing mechanisms of resistance to PARP inhibitorsLorena Incorvaia, Francesc Passiglia, Sergio Rizzo, et al.
Current Cancer Drug Targets|March 10, 2018
Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled AnalysisFrancesco Passiglia, Sergio Rizzo, Christian Rolfo, et al.
Oncotarget|July 31, 2016
Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathwayDaniela Massihnia, Antonio Galvano, Daniele Fanale, et al.
Oncology|December 17, 2013
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer populationVincenzo Adamo, Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, et al.
Critical Reviews in Oncology/Hematology|November 9, 2016
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?Giuseppe Bronte, Lorena Incorvaia, Sergio Rizzo, et al.
Pageof 7